| | | | | |
PLMK Plum Acquisition Corp. IV Class A Ordinary Shares | €9,1504 | -0,05% | €221,62M | €31,34K | |
DMAA Drugs Made In America Acquisition Corp. Ordinary Shares | €9,1246 | +0,00% | €221,51M | €122,98 | |
ERC Allspring Multi-Sector Income Fund | €7,8045 | +0,06% | €221,47M | €32,88K | |
GLO Clough Global Opportunities Fund | €5,2133 | +0,45% | €221,40M | €44,89K | |
NTWO Newbury Street II Acquisition Corp Class A Ordinary Shares | €9,1719 | +0,24% | €221,29M | €1,720 | |
TRGS TRG Latin America Acquisitions Corp. Class A Ordinary Shares | €8,4959 | -0,01% | €220,82M | €14,03K | |
CPZ Calamos Long/Short Equity & Dynamic Income Trust Common Stock | €11,0424 | -0,08% | €220,33M | €30,30K | |
| €3,3841 | +1,42% | €220,07M | €83,50K | |
ALXO ALX Oncology Holdings Inc. Common Stock | €1,4921 | +3,89% | €219,87M | €284,96K | |
PNNT Pennant Investment Corp | €3,4529 | +3,21% | €219,56M | €330,82K | |
VNME Vendome Acquisition Corporation I Class A Ordinary Shares | €8,7763 | -0,05% | €219,29M | €94,60 | |
NUW Nuveen AMT-Free Municipal Value Fund | €12,0340 | +0,24% | €219,22M | €32,41K | |
| €33,9442 | +3,54% | €219,21M | €2,62K | |
DSP Viant Technology Inc. Class A Common Stock | €10,5694 | +1,57% | €219,02M | €60,03K | |
| €24,9916 | +1,75% | €218,91M | €24,73K | |
